Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)

REFERENCES

• Gerdes J., Schwab U., Lemke H., Stein H. Production of aMouse Monoclonal Antibody Reactive with a Human Nuclear Antigen Associated with Cell Proliferation. Int. J. Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar
• Key G., Becker M. H., Baron B., Duchrow M., Schlüter C., Flad H. D., Gerdes J. New Ki-67-Equivalent Murine Monoclonal Antibodies (MIB 1–3) Generated Against Bacterially Expressed Parts of the Ki-67 cDNA Containing Three 62 Base Pair Repetitive Elements Encoding for the Ki-67 Epitope. Lab. Invest 1993; 68: 629–636
   PubMed Web of Science ®Google Scholar
• Kubbutat M. H., Key G., Duchrow M., Schlüter C., Flad H. D., Gerdes J. Epitope Analysis of Antibodies Recognising the Cell Proliferation Associated Nuclear Antigen Previously Defined by the Antibody Ki-67 (Ki-67 Protein). J. Clin. Pathol. 1994; 47: 524–528
   PubMed Web of Science ®Google Scholar
• Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell Cycle Analysis of a Cell Proliferation-Associated Human Nuclear Antigen Defined by the Monoclonal Antibody Ki-67. J. Immunol. 1984; 133: 1710–1715
   PubMed Web of Science ®Google Scholar
• Brown D. C., Gatter K. C. Monoclonal Antibody Ki-67: Its Use in Histopathology. Histopathology 1990; 17: 489–503
   PubMed Web of Science ®Google Scholar
• Gerdes J. Ki-67 and Other Proliferation Markers Useful for Immunohistological Diagnostic and Prognostic Evaluations in Human Malignancies. Semin. Cancer Biol. 1990; 1: 199–206
   PubMedGoogle Scholar
• Gerdes J., Stein H., Pileri S., Rivano M. T., Gobbi M., Ralfkiaer E., Nielsen K. M., Pallesen G., Bartels H., Palestro G., Delsol G. Prognostic Relevance of Tumour-Cell Growth Fraction in Malignant Non-Hodgkin's Lymphomas. Lancet 1987; 2(8556)448–449
   PubMed Web of Science ®Google Scholar
• Hall P. A., Richards M. A., Gregory W. M., d'Ardenne A. J., Lister T. A., Stansfeld A. G. The Prognostic Value of Ki67 Immunostaining in Non-Hodgkin's Lymphoma. J. Pathol. 1988; 154: 223–235
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Spier C. M., Richter L. C., Rangel C. S. Immunologic Approaches to the Classification of Non-Hodgkin's Lymphomas. Cancer Treat. Res. 1988; 38: 31–148
   PubMedGoogle Scholar
• Holte H., de Lange Davies C., Beiske K., Stokke T., Marton P. F., Smeland E. B., Hoie J., Kvaloy S. Ki67 and 4F2 Antigen Expression as Well as DNA synthesis Predict Survival at Relapse/Tumour Progression in Low-Grade B-Cell Lymphoma. Int. J. Cancer 1989; 44: 975–980
   PubMed Web of Science ®Google Scholar
• Nicholson R. I., Bouzubar N., Walker K. J., McClelland R., Dixon A. R., Robertson J. F., Ellis I. O., Blamey R. W. Hormone Sensitivity in Breast Cancer: Influence of Heterogeneity of Oestrogen Receptor Expression and Cell Proliferation. Eur. J. Cancer 1991; 27: 908–913
   PubMed Web of Science ®Google Scholar
• Wintzer H. O., Zipfel I., Schulte Monting J., Hellerich U., von Kleist S. Ki-67 Immunostaining in Human Breast Tumors and Its Relationship to Prognosis. Cancer 1991; 67: 421–428
   PubMed Web of Science ®Google Scholar
• Locker A. P., Birrell K., Bell J. A., Nicholson R. I., Elston C. W., Blamey R. W., Ellis I. O. Ki67 Immunoreactivity in Breast Carcinoma: Relationships to Prognostic Variables and Short Term Survival. Eur. J. Surg. Oncol. 1992; 18: 224–229
   PubMedGoogle Scholar
• Tungekar M. F., Gatter K. C., Dunnill M. S., Mason D. Y. Ki-67 Immunostaining and Survival in Operable Lung Cancer. Histopathology 1991; 19: 545–550
   PubMed Web of Science ®Google Scholar
• Ueda T., Aozasa K., Tsujimoto M., Ohsawa M., Uchida A., Aoki Y., Ono K., Matsumoto K. Prognostic Significance of Ki-67 Reactivity in Soft Tissue Sarcomas. Cancer 1989; 63: 1607–1611
   PubMed Web of Science ®Google Scholar
• Fontana D., Bellina M., Gubetta L., Fasolis G., Rolle L., Scoffone C., Propiglia F., Colombo M., Tarabuzzi R., Leonardo E. Monoclonal Antibody Ki-67 in the Study of the Proliferative Activity of Bladder Carcinoma. J. Urol. 1992; 148: 1149–1151
   PubMed Web of Science ®Google Scholar
• Gerdes J., Li L., Schlüter C., Duchrow M., Wohlenberg C., Gerlach C., Stahmer I., Kloth S., Brandt E., Flad H. D. Immunobiochemical and Molecular Biologic Characterization of the Cell Proliferation-Associated Nuclear Antigen That Is Defined by Monoclonal Antibody Ki-67. Am. J. Pathol. 1991; 138: 867–873
   PubMed Web of Science ®Google Scholar
• Duchrow M., Gerdes J., Schlüter C. The Proliferation-Associated Ki-67 Protein: Definition in Molecular Terms. Cell Prolif. 1994; 27: 235–242
   PubMed Web of Science ®Google Scholar
• Schlüter C., Duchrow M., Wohlenberg C., Becker M. H., Key G., Flad H. D., Gerdes J. The Cell Proliferation-Associated Antigen of Antibody Ki-67: A Very Large, Ubiquitous Nuclear Protein with Numerous Repeated Elements, Representing a New Kind of Cell Cycle-Maintaining Proteins. J. Cell Biol. 1993; 123: 513–522
   PubMed Web of Science ®Google Scholar
• Duchrow M., Schlüter C., Wohlenberg C., Flad H. D., Gerdes J. Molecular Characterization of the Gene Locus of the Human Cell Proliferation-Associated Nuclear Protein Defined by Monoclonal Antibody Ki-67. Cell Prolif. 1996; 29: 1–12
   PubMed Web of Science ®Google Scholar
• Hermanek P. [1992 Tumor Classification/Developments]. Langenbecks Arch. Chir. Suppl. Kongressbd. 1992; 40–45
   PubMedGoogle Scholar
• Cattoretti G., Becker M H., Key G., Duchrow M., Schlüter C., Galle J., Gerdes J. Monoclonal Antibodies Against Recombinant Parts of the Ki-67 Antigen (MIB 1 and MIB 3) Detect Proliferating Cells in Microwave-Processed Formalin-Fixed Paraffin Sections. J. Pathol. 1992; 168: 357–363
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Kaplan K. P., Meier P. Nonparametric Estimation from Incomplete Observations. J. Am. Stat. Assoc. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Porschen R., Lohe B., Hengels K. J., Borchard F. Assessment of Cell Proliferation in Colorectal Carcinomas Using the Monoclonal Antibody Ki-67. Correlation with Pathohistologic Criteria and Influence of Irradiation. Cancer 1989; 64: 2501–2505
   PubMed Web of Science ®Google Scholar
• Kubota Y., Petras R. E., Easley K. A., Bauer T. W., Tubbs R. R., Fazio V. W. Ki-67-Determined Growth Fraction Versus Standard Staging and Grading Parameters in Colorectal Carcinoma. A Multivariate Analysis. Cancer 1992; 70: 2602–2609
   PubMed Web of Science ®Google Scholar
• Diebold J., Dopfer K., Lai M., Lohrs U. Comparison of Different Monoclonal Antibodies for the Immunohistochemical Assessment of Cell Proliferation in Routine Colorectal Biopsy Specimens. Scand. J. Gastroenterol. 1994; 29: 47–53
   PubMed Web of Science ®Google Scholar
• Jansson A., Sun X. F. Ki-67 Expression in Relation to Clinicopathological Variables and Prognosis in Colorectal Adenocarcinomas. Acta Pathol. Microbiol. Immunol. Scand. 1997; 105: 730–734
   PubMed Web of Science ®Google Scholar
• Ofner D., Grothaus A., Riedmann B., Larcher P., Maier H., Bankfalvi A., Schmid K. W. MIB1 in Colorectal Carcinomas: Its Evaluation by Three Different Methods Reveals Lack of Prognostic Significance. Anal. Cell Pathol. 1996; 12: 61–70
   PubMedGoogle Scholar
• al Sheneber I. F., Shibata H. R., Sampalis J., Jothy S. Prognostic Significance of Proliferating Cell Nuclear Antigen Expression in Colorectal Cancer. Cancer 1993; 71: 1954–1959
   PubMed Web of Science ®Google Scholar
• Mayer A., Takimoto M., Fritz E., Schellander G., Kofler K., Ludwig H. The Prognostic Significance of Proliferating Cell Nuclear Antigen, Epidermal Growth Factor Receptor, and mdr Gene Expression in Colorectal Cancer. Cancer 1993; 71: 2454–2460
   PubMed Web of Science ®Google Scholar
• van Oijen M. G., Medema R. H., Slootweg P. J., Rijksen G. Positivity of the Proliferation Marker Ki-67 in Noncycling Cells. Am. J. Clin. Pathol. 1998; 110: 24–31
   PubMed Web of Science ®Google Scholar
• Hemming A. W., Davis N. L., Kluftinger A., Robinson B., Quenville N. F., Liseman B., LeRiche J. Prognostic Markers of Colorectal Cancer: An Evaluation of DNA Content, Epidermal Growth Factor Receptor, and Ki-67. J. Surg. Oncol. 1992; 51: 147–152
   PubMed Web of Science ®Google Scholar
• Mori M., Kakeji Y., Adachi Y., Moriguchi S., Maehara Y., Sugimachi K., Jessup J. M., Chen L. B., Steele G. D.J. The Prognostic Significance of Proliferating Cell Nuclear Antigen in Clinical Gastric Cancer. Surgery 1993; 113: 683–690
   PubMed Web of Science ®Google Scholar
• Bruno S., Darzynkiewicz Z. Cell Cycle Dependent Expression and Stability of the Nuclear Protein Detected by Ki-67 Antibody in HL-60 Cells. Cell Prolif. 1992; 25: 31–40
   PubMed Web of Science ®Google Scholar